Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Retained Earnings (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Retained Earnings data on record, last reported at -$1.4 billion in Q3 2025.

  • For Q3 2025, Retained Earnings fell 12.64% year-over-year to -$1.4 billion; the TTM value through Sep 2025 reached -$1.4 billion, down 12.64%, while the annual FY2024 figure was -$1.3 billion, 362348.0% down from the prior year.
  • Retained Earnings reached -$1.4 billion in Q3 2025 per GOSS's latest filing, down from -$1.3 billion in the prior quarter.
  • Across five years, Retained Earnings topped out at -$350000.0 in Q4 2023 and bottomed at -$1.4 billion in Q3 2025.
  • Average Retained Earnings over 4 years is -$863.8 million, with a median of -$1.1 billion recorded in 2023.
  • Peak YoY movement for Retained Earnings: soared 99.97% in 2023, then plummeted 362348.0% in 2024.
  • A 4-year view of Retained Earnings shows it stood at -$1.0 billion in 2022, then skyrocketed by 99.97% to -$350000.0 in 2023, then tumbled by 362348.0% to -$1.3 billion in 2024, then fell by 9.71% to -$1.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$1.4 billion in Q3 2025, -$1.3 billion in Q2 2025, and -$1.3 billion in Q1 2025.